Velan Investor Presentation Q1 F2024
EBITDA 1 evolution
Historic ($m)
18
16
14
12
Restructuring
and
10
transformation
income
8
6
4
2
0
-2
-4
-56
J
2019
2020
2021
2022
Adj. to asbestos
provision
2023
2024
-2,9
1,8
Q1 Bridge ($m)
-0,9
1,6
1,6
4,3
0,2
-3,8
Q1 F2023
Volume
Mix
FX
Administration
costs
Other
Q1 F2024
Q1 F2024 gross profit negatively impacted by a lower sales volume, a less efficient product mix delivered, and negative FX fluctuations compared to prior
The decrease was partially offset by lower administration costs, primarily related to asbestos settlements costs, which were provided for in Q4 F2023.
year.
1 Non-IFRS and supplementary financial measures - additional specifications at the end of this presentation
VELAN
2 Primarily due to a $9.6 m gain on the disposal of a plant. See MD&A for more details.View entire presentation